Nisa Investment Advisors
AXSM icon

Nisa Investment Advisors’s Axsome Therapeutics AXSM Stock Holding History

Nisa Investment Advisors’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$215K Sell
880
-159
-15% -$34.5K ﹤0.01% 1222
2026
Q1 		$176K Buy
1,039
+3
+0.3% +$518 ﹤0.01% 1255
2025
Q4 		$189K Sell
1,036
-46
-4% -$6.42K ﹤0.01% 1244
2025
Q3 		$131K Buy
1,082
+55
+5% +$6.2K ﹤0.01% 1362
2025
Q2 		$107K Sell
1,027
-20
-2% -$2.12K ﹤0.01% 1372
2025
Q1 		$122K Sell
1,047
-26
-2% -$2.96K ﹤0.01% 1346
2024
Q4 		$90.8K Buy
1,073
+50
+5% +$4.6K ﹤0.01% 1500
2024
Q3 		$91.9K Buy
1,023
+37
+4% +$3.23K ﹤0.01% 1470
2024
Q2 		$79.4K Buy
986
+39
+4% +$2.89K ﹤0.01% 1533
2024
Q1 		$75.6K Buy
947
+26
+3% +$2.18K ﹤0.01% 1554
2023
Q4 		$73.3K Buy
921
+5
+0.5% +$334 ﹤0.01% 1529
2023
Q3 		$64K Hold
916
– – ﹤0.01% 1657
2023
Q2 		$65.8K Buy
916
+90
+11% +$6.64K ﹤0.01% 1650
2023
Q1 		$51K Hold
826
– – ﹤0.01% 1708
2022
Q4 		$64K Hold
826
– – ﹤0.01% 1695
2022
Q3 		$37K Sell
826
-62
-7% -$3.1K ﹤0.01% 1850
2022
Q2 		$34K Buy
888
+600
+208% +$19K ﹤0.01% 1867
2022
Q1 		$12K Sell
288
-1,790
-86% -$55.5K ﹤0.01% 2161
2021
Q4 		$57K Buy
2,078
+1,588
+324% +$58.4K ﹤0.01% 1690
2021
Q3 		$16K Sell
490
-2,181
-82% -$85K ﹤0.01% 2131
2021
Q2 		$180K Sell
2,671
-250
-9% -$15K ﹤0.01% 1447
2021
Q1 		$165K Hold
2,921
– – ﹤0.01% 1545
2020
Q4 		$238K Buy
2,921
+1,206
+70% +$90.2K ﹤0.01% 1399
2020
Q3 		$122K Sell
1,715
-797
-32% -$62.1K ﹤0.01% 1488
2020
Q2 		$207K Buy
2,512
+2,292
+1,042% +$176K ﹤0.01% 1275
2020
Q1 		$13K Sell
220
-80
-27% -$6.52K ﹤0.01% 1798
2019
Q4 		$31K Hold
300
– – ﹤0.01% 1611
2019
Q3 		$6K Buy
+300
New +$7.71K ﹤0.01% 1870

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Nisa Investment Advisors's AXSM Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Axsome Therapeutics (AXSM) stake by 15% in Q2 2026, selling an estimated $34.5K and leaving 880 shares worth $215K. The position accounts for ﹤0.01% of the portfolio, ranked #1222.

Nisa Investment Advisors first reported a position in AXSM in Q3 2019 and has held it in 28 quarters since. The position peaked at $238K in Q4 2020. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • Nisa Investment Advisors held 880 shares of Axsome Therapeutics worth $215K as of Q2 2026.
  • Nisa Investment Advisors sold 159 Axsome Therapeutics shares in Q2 2026, an estimated $34.5K.
  • Axsome Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1222 holding.
  • Nisa Investment Advisors first reported a position in Axsome Therapeutics in Q3 2019 and has held it in 28 quarters since.
  • Nisa Investment Advisors's Axsome Therapeutics position peaked at $238K in Q4 2020.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.